Solid Organ Transplant Clinical Trial
Official title:
Discharge to Home and Chronic Illness Care Pilot
NCT number | NCT02165423 |
Other study ID # | CHW 14/66 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | June 2014 |
Est. completion date | October 2018 |
Verified date | March 2019 |
Source | Medical College of Wisconsin |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to address a gap in knowledge needed for care of children with solid organ transplantation (SOT) and their parents by combining mHealth technology with an individualized family centered self-management intervention (referred to as myFAMI). This study is critical to the increased understanding of hospital to home transition and family management at home with the potential to transform the way clinicians approach the care of complex chronic illness children and families.
Status | Completed |
Enrollment | 20 |
Est. completion date | October 2018 |
Est. primary completion date | October 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 90 Years |
Eligibility |
Inclusion Criteria: - parent's child has undergone a heart, kidney, or liver transplant and is being discharged home from the hospital - the parent is English speaking (to date the tools being used have been validated for English participants only) - parent is 18 years of age or older - patient is 17 years of age and younger. Exclusion Criteria: - presence of significant communication or cognitive impairment on the part of the parent that would preclude completion of questionnaires based on self-report - parent and child has experienced the discharge to home transition from a previous transplant. |
Country | Name | City | State |
---|---|---|---|
United States | Children's Hospital of Wisconsin | Milwaukee | Wisconsin |
Lead Sponsor | Collaborator |
---|---|
Medical College of Wisconsin | Children's Research Institute |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Evaluate the effectiveness of myFAMI on 30-day post-discharge outcomes. | Hypothesis: Compared to parents who received standard discharge preparation (usual care), parents receiving myFAMI will report: i) Better care coordination, ii) Higher quality of discharge teaching, iii) Greater readiness for hospital discharge, iv) Improved post-discharge coping, v) Improved family functioning, vi) Better self-management of medication and treatment regimens vii) Fewer emergency department visits and hospital readmissions |
30 days following enrollment | |
Secondary | Examine the acceptability of myFAMI: | 2. Examine the acceptability of myFAMI: The content of the interview will focus on strengths and weaknesses of iPad® technology in preparing parents for hospital discharge utilizing both survey and qualitative questions | Enrollment plus 30 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03950414 -
A Dose-Escalation Study Evaluating Safety and Tolerability of Viral-Specific T Cells Against CMV in Adult Solid Organ Transplant Recipients
|
Phase 1 | |
Recruiting |
NCT05663463 -
Seasonal Influenza Vaccine High Dose Boosting in Solid Organ Transplant Recipients
|
N/A | |
Completed |
NCT05124509 -
Immune Response to Third Dose of COVID-19 Vaccine in Solid Organ Transplant
|
||
Completed |
NCT05121142 -
Study of Ruxolitinib for Acute and Chronic Graft Versus Host Disease
|
Phase 1 | |
Completed |
NCT01058239 -
Bortezomib Plus Rituximab for EBV+ PTLD
|
Phase 2 | |
Withdrawn |
NCT03327987 -
Early Flu Shots in SOT
|
||
Completed |
NCT04253548 -
iPeer2Peer Pediatric Thoracic Transplantation
|
N/A | |
Recruiting |
NCT05164016 -
Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients
|
||
Withdrawn |
NCT02464306 -
Fidaxomicin Versus Standard of Care Therapy in Solid Organ Transplant Recipients With Clostridium Difficile Infection
|
Phase 4 | |
Completed |
NCT00907023 -
Transition From Hospital to Home in Solid Organ Transplant (SOT)
|
N/A | |
Recruiting |
NCT04613206 -
High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients
|
Phase 2 | |
Recruiting |
NCT05550298 -
Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients
|
||
Completed |
NCT00518778 -
Fusariosis in Solid-Organ Transplant Recipients
|
N/A | |
Active, not recruiting |
NCT04331275 -
Viral Specific T-cells for Treatment of Viral Infections After Solid Organ Transplant
|
Phase 2 | |
Recruiting |
NCT05968807 -
iParent2Parent Program for Parents of Pediatric Solid Organ Transplant Recipients
|
N/A | |
Active, not recruiting |
NCT03482739 -
Safety, Tolerability and Immunogenicity of a Nine-valent Human Papillomavirus (HPV) Vaccine in HIV and Transplant Patients
|
Phase 3 | |
Not yet recruiting |
NCT04721288 -
REmote moBile Outpatient mOnitoring in Transplant 2.0
|
N/A | |
Completed |
NCT04844489 -
Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People
|
N/A | |
Active, not recruiting |
NCT03360682 -
Clinical Trial to Evaluate the Efficacy, Pharmacokinetics (PK) Interactions and Safety of Dolutegravir Plus 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in HIV‐1‐Infected Solid Organ Transplant Patients
|
Phase 4 |